BTK-IN-19
BTK-IN-19 (Compound 51) is a reversible BTK inhibitor with an IC50 of [1].
Product Specifications
CAS Number
[1374240-01-3]
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/btk-in-19.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC(Cl)=CC(NCC(N2C[C@]3([H])N(C4=C5C(NC=C5)=NC=N4)CC[C@]3([H])CC2)=O)=C1
Molecular Formula
C21H22Cl2N6O
Molecular Weight
445.34
References & Citations
[1]Vandeveer GH, et al. Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. Bioorg Med Chem Lett. 2022 Dec 17;80:129108.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1471970-01 0.02 mg (E-Coli)
Recombinant Saccharophagus degradans 3-isopropylmalate dehydratase small subunit (leuD)
Ask
View Details 
MBS1471970-02 0.1 mg (E-Coli)
Recombinant Saccharophagus degradans 3-isopropylmalate dehydratase small subunit (leuD)
Ask
View Details MBS1471970-03 0.02 mg (Yeast)
Recombinant Saccharophagus degradans 3-isopropylmalate dehydratase small subunit (leuD)
Ask
View Details MBS1471970-04 0.1 mg (Yeast)
Recombinant Saccharophagus degradans 3-isopropylmalate dehydratase small subunit (leuD)
Ask
View Details